GlassScriptPhysician profile
Evelyn D Morning
NPI 1154490720
$1,797.71
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $551 · 2020: $189 · 2021: $313 · 2022: $236 · 2023: $350 · 2024: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.00 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $386.56 | 2019-2023 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
| Abbvie INC. | $299.18 | 2019-2022 | |
| Exeltis, USA INC. | $156.02 | 2019-2024 | Slynd |
| Astellas Pharma US INC | $135.12 | 2023-2024 | Veozah |
| Roche Diagnostics Corporation | $128.52 | 2019-2020 | |
| Therapeuticsmd, INC. | $109.26 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $100.00 | 2019 | |
| Pfizer INC. | $99.85 | 2023-2024 | |
| Smith+Nephew, INC. | $97.68 | 2019 | |
| Avion Pharmaceuticals | $84.77 | 2019-2023 | Balcoltra |
| Millicent US INC | $45.12 | 2019-2023 | Femring, Intrarosa |
| Myovant Sciences INC. | $41.67 | 2021-2022 | |
| Amgen INC. | $41.02 | 2019-2024 | Evenity |
| Amag Pharmaceuticals, INC. | $18.60 | 2019 | |
| Evofem Biosciences, INC. | $16.43 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $13.44 | 2019 | |
| Merck Sharp & Dohme LLC | $13.08 | 2019 | |
| Zyla Life Sciences, INC. | $11.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evelyn Morning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.